Scalper1 News
Today’s Screen of the Day features four institutional-quality drug and medical Big Caps stocks with solid fundamentals. Jazz Pharmaceuticals (JAZZ), which has a market cap of $9.85 billion, earned an IBD Composite Rating of 99, which means that it has outperformed 99% of all stocks in key metrics such as earnings and sales. Best-selling narcolepsy medication Xyrem made up two-thirds of Jazz’s second-quarter sales. The company acquired Italian Scalper1 News
Scalper1 News